Treatment of corticosteroid-resistant polymyositis with methotrexate.
D000284:Administration, Oral; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D002908:Chronic Disease; D003882:Dermatomyositis / Q000188:drug therapy* / Q000201:enzymology; D006801:Humans; D007275:Injections, Intravenous; D008111:Liver Function Tests; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D009135:Muscular Diseases / Q000188:drug therapy* / Q000201:enzymology; D011241:Prednisone / Q000627:therapeutic use; D013997:Time Factors
D000305:Adrenal Cortex Hormones; D011241:Prednisone; D008727:Methotrexate